# Xlcare Pharmaceuticals Inc.

Canonical: https://abierto.us/vendors/xlcare-pharmaceuticals-inc-meaus5whbjj7

- UEI: MEAUS5WHBJJ7
- CAGE: 86SL9
- Parent: Cipla USA Inc.
- Location: Lawrenceville, GA
- Awards in window: 20 (168 transactions), $0 obligated, January 9, 2024 to September 3, 2026

## Awarding agencies

- Department of Veterans Affairs: 20 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 20 awards

## Solicitations won

- XLCare Pharmaceuticals, Inc. (June 1, 2026 - May 31, 2031 (36F79726D0120), $50,000,000. https://abierto.us/opportunities/36f79726d0120
- Allopurinol Tablets Effective May 30, 2026 to May 29, 2027 (36E79725R0067), $17,786,862. https://abierto.us/opportunities/36e79725r0067
- Levetiracetam Tablets (36E79726R0001), $9,568,741. https://abierto.us/opportunities/36e79726r0001
- Carbidopa Levodopa Immediate Release (IR) Tablets (36E79726R0008). https://abierto.us/opportunities/36e79726r0008
- Montelukast 10mg Tablet (36E79725R0061), $24,826,671. https://abierto.us/opportunities/36e79725r0061
- Losartan Tablets (36E79725R0032), $37,933,103. https://abierto.us/opportunities/36e79725r0032
- Topiramate Tablets (36E79725R0031), $14,134,788. https://abierto.us/opportunities/36e79725r0031
- Levothyroxine Tablets XLCare Pharmaceuticals, Inc. Base Year Ordering Period: 1/27/2025 - 1/26/2026 (36E79724R0020), $40,144,392. https://abierto.us/opportunities/36e79724r0020
- Oxcarbazepine RFP (36E79724R0021). https://abierto.us/opportunities/36e79724r0021
- Methocarbamol Tablets (36E79724R0005), $11,608,274. https://abierto.us/opportunities/36e79724r0005

## Largest awards

- 36E79720D0038: $0, Nac Pharmaceuticals. Change Timeframe for the Submission of Quarterly Sales Reports and Cost Recovery Fee to 30 Calendar Days After End of Each Fiscal Quarter.. https://www.usaspending.gov/award/CONT_IDV_36E79720D0038_3600/
- 36E79720D0049: $0, Nac Pharmaceuticals. CRF Payment and Sales Reporting Updates. https://www.usaspending.gov/award/CONT_IDV_36E79720D0049_3600/
- 36E79720D0073: $0, Nac Pharmaceuticals. Exercising Option Year 3 of 36E79720D0073. https://www.usaspending.gov/award/CONT_IDV_36E79720D0073_3600/
- 36E79721D0027: $0, Nac Pharmaceuticals. Cost Recovery Fee and Submission of Quarterly Sales Reports Changes Effective 2/9/2024 for Montelukast Na Tablets with Xlcare Pharmaceuticals, INC.. https://www.usaspending.gov/award/CONT_IDV_36E79721D0027_3600/
- 36E79721D0031: $0, Nac Pharmaceuticals. 52.212-4(C) Contract Terms and Conditions - Changes Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports 36E79721D0031 Xlcare Pharmaceuticals, INC Levetiracetam Tablets. https://www.usaspending.gov/award/CONT_IDV_36E79721D0031_3600/
- 36E79721D0051: $0, Nac Pharmaceuticals. Cost Recovery Fee Change. https://www.usaspending.gov/award/CONT_IDV_36E79721D0051_3600/
- 36E79722D0023: $0, Nac Pharmaceuticals. This Modification Is Issued to Update the Terms of the CRF Payment Remittal and Submission of Quarterly Sales Reports.. https://www.usaspending.gov/award/CONT_IDV_36E79722D0023_3600/
- 36E79723D0018: $0, Nac Pharmaceuticals. CRF Sales Submittal and Reporting Changes. https://www.usaspending.gov/award/CONT_IDV_36E79723D0018_3600/
- 36E79723D0027: $0, Nac Pharmaceuticals. Cost Recovery Fee and Submission of Quarterly Sales Report Changes Effective 2/9/2024 for Gabapentin Capsules with Xlcare Pharmaceuticals, INC.. https://www.usaspending.gov/award/CONT_IDV_36E79723D0027_3600/
- 36E79724D0018: $0, Nac Pharmaceuticals. Award to Xlcare Pharmaceuticals for Methocarbamol Tablets for the Base Year with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79724D0018_3600/
- 36E79724D0034: $0, Nac Pharmaceuticals. New Award for Oxcarbazepine with Xlcare Pharmaceuticals. Period of Performance Is Oct 14, 2024 to Oct 13, 2025 with Four ONE-YEAR Options. https://www.usaspending.gov/award/CONT_IDV_36E79724D0034_3600/
- 36E79725D0004: $0, Nac Pharmaceuticals. New Award for Levothyroxine Na Tablets with Xlcare Pharmaceuticals, INC. Base Year Ordering Period Is Jan 27, 2025 Through Jan 26, 2026 with Four ONE-YEAR Options. https://www.usaspending.gov/award/CONT_IDV_36E79725D0004_3600/
- 36E79725D0037: $0, Nac Pharmaceuticals. New Award for Losartan Tablets with Xlcare Pharmaceuticals, INC. Period of Performance Is 9/24/2025-9/23/2026.. https://www.usaspending.gov/award/CONT_IDV_36E79725D0037_3600/
- 36E79725D0045: $0, Nac Pharmaceuticals. New Award for Topiramate Tablets with Xlcare. Ordering Period Is Oct 31, 2025 to Oct 30, 2026 with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79725D0045_3600/
- 36E79726D0007: $0, Nac Pharmaceuticals. 3 Line Items for Montelukast 10MG Tablet. Awarded for a Base Year of 5/10/2026 to 5/9/2027 Plus 4 ONE-YEAR Option Periods.. https://www.usaspending.gov/award/CONT_IDV_36E79726D0007_3600/
- 36E79726D0019: $0, Nac Pharmaceuticals. New Award for Levetiracetam Tablets with Xlcare Pharmaceuticals. Ordering Period Feb 5, 2026 to May 23, 2026, with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79726D0019_3600/
- 36E79726D0024: $0, Nac Pharmaceuticals. New Award for Allopurinol Tablets with Xlcare Pharmaceuticals, INC. Ordering Period Is May 30, 2026 to May 29, 2027 with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79726D0024_3600/
- 36E79726D0027: $0, Nac Pharmaceuticals. New Award for Carbidopa/Levodopa Immediate-Release (Ir) Tablets with Xlcare Pharmaceuticals, INC. Ordering Period Is June 21, 2026 to June 20, 2027 with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79726D0027_3600/
- 36F79721D0091: $0, Nac Federal Supply Schedule. Temporary Price Decrease. https://www.usaspending.gov/award/CONT_IDV_36F79721D0091_3600/
- 36F79726D0120: $0, Nac Federal Supply Schedule. 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award. https://www.usaspending.gov/award/CONT_IDV_36F79726D0120_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/xlcare-pharmaceuticals-inc-meaus5whbjj7.